Unmet Needs Index — Biopharma Disease Prioritization
Explore unmet medical needs across 2,400+ diseases scored by efficacy gaps, safety burden, and pipeline activity. Built by Convoke for biopharma R&D teams.
Unmet Needs Index — Biopharma Disease Prioritization Introducing the Unmet Needs Index There are thousands of named human diseases, many of which are rare and obscure. Within each disease, there are yet more subsegments of distinct biology that require their own distinct treatments. With so many patients in need of better drugs, it's hard for a drug developer to know which particular problems to focus on. Because this problem space is so immense, drug developers often focus on solving unmet needs that are visible to them. If you read the history of some of our most impactful therapeutics, it i
saved by
related reading
- benchmarks.bio — Agentic benchmarks on messy, real-world biological databenchmarks.bio
- BenchmarkList: Track the Frontier of AI Capabilitiesbenchmarklist.com
- Gap Mapgap-map.org
- Manifold Bio | Tissue-targeted medicines, designed in vivomanifold.bio
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Convoke | Biopharma's Operating Systemconvoke.bio
- The Business of Extracting Knowledge from Academic Publicationsmarkusstrasser.org
- the drug landscapegenome-browser-eight.vercel.app
- Elicit: AI for scientific researchelicit.com
- Convictionconviction.com
- Systematic integration of biomedical knowledge prioritizes drugs for repurposinggit.dhimmel.com
- Elicit: AI for scientific researchelicit.org